PostEra announces expansion to $610M in their AI drug discovery collaboration with Pfizer

BOSTON, Jan. 7, 2025 /PRNewswire/ — PostEra, a biotechnology company specializing in machine learning for preclinical drug discovery, today announced an expansion of their partnership with Pfizer. The parties will launch a new Antibody-Drug-Conjugate (ADC) collaboration while also expanding their existing $260MAI Lab collaboration, which itself was built upon a successful Generative Chemistry partnership. The […] L'articolo PostEra announces expansion to $610M in their AI drug discovery collaboration with Pfizer proviene da La Ragione.

CONTINUA A LEGGERE